Delivery Order SPE2DR25D9112-SPE2DR26FDEQ2
- Not listed
- The Defense Logistics Agency awarded a $12,364.81 delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for 60 tablets of Jakafi 10 mg. The award, issued on December 8, 2025, with an ultimate completion date of December 9, 2025, carries no set-aside designation and utilizes firm fixed-price pricing. This delivery order is issued under DMS Pharmaceutical Group's Indefinite Delivery Contract with the Defense Logistics...
- The Defense Logistics Agency issued a firm fixed-price delivery order valued at $12,364.81 to DMS Pharmaceutical Group Inc. for 60 tablets of Jakafi 10 mg, with a completion date of December 31, 2025. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, was selected without a set-aside designation, demonstrating the company's competitive capability in unrestricted federal procurement. This delivery order was issued under the...
- The Defense Logistics Agency issued a delivery order valued at $12,364.81 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for 60 tablets of Jakafi 10 mg. The delivery order, issued on December 17, 2025, with an ultimate completion date of December 18, 2025, utilizes firm fixed-price pricing with no set-aside designation, allowing DMS Pharmaceutical Group to compete directly against other qualified vendors. This award falls...
- The Defense Logistics Agency awarded a delivery order valued at $25,326.56 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, for the supply of Jakafi 10 mg tablets (60-count). This firm fixed-price delivery order, with an ultimate completion date of January 9, 2026, was issued without a set-aside designation, demonstrating the contractor's competitive capability in unrestricted federal procurement. The award is...
- The Defense Logistics Agency awarded a delivery order valued at $24,793.16 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, for the supply of Jakafi 5 mg tablets (60-count units). The contract is firm fixed-price with no set-aside designation and has an ultimate completion date of December 17, 2025. This delivery order is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract (IDC) with the...
- The Defense Logistics Agency awarded a delivery order valued at $24,676.82 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, for the supply of Jakafi 20 mg tablets (60-count units). The award was issued on December 23, 2025, with an ultimate completion date of December 24, 2025, under a firm fixed-price contract type with no set-aside designation. This delivery order was issued under DMS Pharmaceutical Group's...
- The Defense Logistics Agency awarded a $12,364.81 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, for 60 tablets of Jakafi 10 mg. The contract was awarded on November 5, 2025, with an ultimate completion date of November 6, 2025, and carries no set-aside designation, indicating the awardee competed in unrestricted federal procurement. This delivery order is issued under DMS...
- The Defense Logistics Agency awarded a $24,729.64 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, for supply of Jakafi 10 mg tablets (60-count units). The delivery order, issued on November 28, 2025, with an ultimate completion date of December 1, 2025, carries no set-aside designation, indicating the award was made through open competition. This delivery order is issued under DMS...
- The Defense Logistics Agency awarded a delivery order valued at $12,364.81 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Jakafi 10 mg tablets (60 count). The award, issued on November 3, 2025, with an ultimate completion date of November 4, 2025, is structured as a firm fixed-price delivery order with no set-aside designation, indicating the vendor competed in an unrestricted procurement. This delivery...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $12,396.58 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Jakafi 5 mg tablets (60 count). This firm fixed-price delivery order, issued on November 24, 2025, with an ultimate completion date of November 25, 2025, was awarded without a set-aside designation, indicating the vendor competed in unrestricted federal procurement. DMS...
- SPE2DR25D9112Indefinite Delivery Contract
- SPE2DR25D9112-SPE2DR26FDEQ2Delivery Order
The Defense Logistics Agency awarded a $25,326.56 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for 60 tablets of Jakafi 10 mg. The award was issued on January 21, 2026, with an ultimate completion date of January 22, 2026, and carries no set-aside designation. This delivery order is issued under DMS Pharmaceutical Group's single-award Indefinite Delivery Contract (IDC) established through the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a $30.3 billion Defense Logistics Agency acquisition strategy that authorizes the company to supply a comprehensive range of pharmaceuticals and medical consumables to Department of Defense healthcare facilities worldwide. DMS Pharmaceutical Group has been registered in the System for Award Management since 2001 and has demonstrated substantial federal contracting capability through numerous delivery orders issued by the Defense Logistics Agency's Medical Supply Chain division. The company's product portfolio encompasses branded and generic prescription medications, biologics, vaccines, and specialty pharmaceuticals supporting military healthcare operations. The PPV-G GEN V contract, awarded on November 13, 2025, has a ceiling value of $499,999,999 and extends through December 31, 2036, featuring a 30-month base period with three 30-month option periods, positioning DMS Pharmaceutical Group as a critical supplier within the federal military pharmaceutical supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $25.3k | 1/20/26 |